Published in PLoS One on June 09, 2015
Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence (2016) 0.78
Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments. Patient Prefer Adherence (2017) 0.75
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients. PLoS One (2015) 0.75
Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum (2006) 10.39
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol (2008) 3.95
Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol (2010) 2.04
Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol (2013) 2.01
From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res (2008) 1.96
Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc (2004) 1.95
Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol (2011) 1.75
A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis (2011) 1.41
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol (2006) 1.30
S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges (2012) 1.25
Adherence in the treatment of psoriasis: a systematic review. Dermatology (2011) 1.21
Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. Br J Dermatol (2011) 1.16
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol (2008) 1.14
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris. Br J Dermatol (2014) 1.00
Prevalence of concern about physical appearance in the general population. Br J Plast Surg (2001) 0.99
Ordering effect and price sensitivity in discrete choice experiments: need we worry? Health Econ (2006) 0.99
Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool. J Invest Dermatol (2011) 0.98
Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis. Arch Dermatol (2007) 0.95
Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol (2012) 0.94
Comorbidities significantly impact patients' preferences for psoriasis treatments. J Am Acad Dermatol (2011) 0.92
Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol (2013) 0.90
Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis. J Eur Acad Dermatol Venereol (2011) 0.90
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol (2011) 0.89
Matching physicians' treatment recommendations to patients' treatment preferences is associated with improvement in treatment satisfaction. J Eur Acad Dermatol Venereol (2012) 0.88
Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. Curr Med Res Opin (2008) 0.86
Elicitation and use of patients' preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol (2012) 0.86
Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions. J Clin Epidemiol (2007) 0.86
Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J Cutan Med Surg (2005) 0.86
Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. Br J Dermatol (2006) 0.85
The framing effect in medical decision-making: a review of the literature. Psychol Health Med (2013) 0.82
Safety of treatment with biologics for psoriasis in daily practice: 5-year data. J Eur Acad Dermatol Venereol (2011) 0.81
Which antipsoriatic drug has the fastest onset of action? Systematic review on the rapidity of the onset of action. J Invest Dermatol (2013) 0.81
Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology (2010) 0.79
Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population. Exp Dermatol (2015) 1.41
Macrophage activation in human diseases. Semin Immunol (2015) 0.82
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells. PLoS One (2014) 0.78
Psychosocial resources and the relationship between transformational leadership and employees' psychological strain. Work (2014) 0.78
Treatment satisfaction of patients with psoriasis. Acta Derm Venereol (2015) 0.78
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients. PLoS One (2015) 0.75
Depression and inflammatory arthritis are associated in both Western and Non-Western countries: Findings from the World Health Survey 2002. J Psychosom Res (2016) 0.75
Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability. J Dtsch Dermatol Ges (2017) 0.75